NAMPT and neoplasm: While a specific receptor for visfatin has not yet been identified, its tumor-promoting effects are dependent on NAMPT enzymatic activity [38] or mediated via transactivation of signaling pathways, such as the PI3K/Akt, MAPK, and STAT3 signaling pathways [33,37].